Tenderwize
Back to tender search

Non-exclusive rebate agreements for dornase alfa

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Nov 30, 2026 · 10 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Dornase alfa (R05CB13) im Rahmen eines sogenannten Open-House-Modells.

55/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

55 / 100

Complexity

63 / 100

Risk factors

No estimated value, guaranteed volume, reimbursement volume, or minimum purchase commitment is provided.

The buyer may introduce exclusive rebate agreements during the term, causing the open-house agreement to end automatica...

Submission deadline in 10 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Nov 30, 2026

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jan 2027
  • Conclusion of non-exclusive rebate agreements under sections 130a(8) and 130c(1) SGB V for medicinal products containing dornase alfa (R05CB13).
  • Participation is offered under an open-house model to all interested pharmaceutical companies, without a selection decision.
Show full summary

Open-house, non-exclusive rebate agreements for medicinal products containing dornase alfa (R05CB13) in Germany. Eligible pharmaceutical companies may join without a selection decision under uniform, non-negotiable conditions. The agreement period runs from 1 February 2025 to 31 January 2027, with monthly accession opportunities. The structured notice gives a final deadline of 30 November 2026, while the notice text states that later accessions are possible until the end of the month preceding the desired start date. No contract value is provided. Procurement documents were not analyzed beyond the extracted XML notice.

Risks

No estimated value, guaranteed volume, reimbursement volume, or minimum purchase commitment is provided.

The buyer may introduce exclusive rebate agreements during the term, causing the open-house agreement to end automatica...

Submission deadline in 10 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only medicinal products authorized and marketable in Germany may be supplied under the agreement.
  • If the product is listed as marketable in the Lauer-Taxe, this is accepted as proof.

Administrative

  • If the product is not yet listed or the entry is not visible, an extract from the public AMIce database must be submitted for each relevant product.

Buyer

Lots (1)

LOT-0000

Dornase Alfa Non-Exclusive Rebate Agreement

Open-house rebate agreement for authorized and marketable medicinal products containing dornase alfa (R05CB13). The agreement is non-exclusive, available to all interested pharmaceutical companies meeting the stated conditions, and uses uniform terms without individual negotiations. Medicinal products included on the BfArM list of paediatric medicines under section 35(5a) SGB V are excluded. Lot information is derived from structured data and the XML notice.

SuppliesEU fundedElectronic submission

Location

DEB3D, Germany

Duration

Jan 2025 - Jan 2027

Category

Pharmaceutical products

Deadline

Deadline Nov 30, 2026

Procurement Details

Publication date
11 Dec 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
759034-2024

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy